Home/Pipeline/Nu.Q® Cancer

Nu.Q® Cancer

Early‑stage solid tumors

DevelopmentActive

Key Facts

Indication

Early‑stage solid tumors

Phase

Development

Status

Active

Company

About VolitionRx

VolitionRx delivers early‑diagnostic blood tests using nucleosome epigenetics for oncology, sepsis and related diseases.

View full company profile

Therapeutic Areas

Oncology Sepsis Inflammation